Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function

Frank D Gilliland1, Kiros Berhane, Yu-Fen Li

  • 1Department of Preventive Medicine, USC Keck School of Medicine, 1540 Alcazar Street, CHP 236, Los Angeles, CA 90033, USA. gillilan@usc.edu

Insights

Maternal smoking during pregnancy and early asthma diagnosis significantly impair lung function in children. These effects are most severe when both in utero smoke exposure and early-onset asthma are present, indicating synergistic impacts on respiratory health.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Health
  • Epidemiology

Background:

  • Maternal smoking in utero and childhood asthma are linked to reduced lung function.
  • The combined impact of prenatal smoke exposure and early asthma diagnosis on lung function requires further investigation.

Purpose of the Study:

  • To examine the effects of in utero smoke exposure and age at asthma diagnosis on lung function in children.
  • To determine if in utero exposure synergistically affects lung function in children with early-onset asthma.

Main Methods:

  • Longitudinal analysis of medical history, tobacco smoke exposure, and lung function data from 5,933 Children's Health Study participants.
  • Comparison of lung function parameters (FEV1, FVC, FEF25-75) based on in utero exposure status and age of asthma diagnosis.

Main Results:

  • In utero exposure without asthma was associated with decreased FEV1/FVC and FEF25-75.
  • Early asthma diagnosis (without in utero exposure) led to greater lung function decline than later diagnosis.
  • Children with both in utero exposure and early-onset asthma exhibited the most significant deficits in lung function, particularly FEV1 and FEF25-75, with effects increasing with age.

Conclusions:

  • In utero exposure to maternal smoking and early-onset asthma have detrimental and potentially synergistic effects on lung function development.
  • These findings highlight the critical importance of preventing prenatal smoke exposure and managing childhood asthma early to mitigate long-term respiratory health consequences.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: